Herlev Hospital in Denmark has ordered a VibroSense Meter system

The department of Clinical Neurophysiology and Nuclear Medicine at the Herlev Hospital in Denmark has ordered a VibroSense Meter device for assessment of impaired sensitivity in hands. The order is regarded as a prestige order and the order value exceeds SEK 160 000.

The CE approved VibroSense Meter device, will be used for research in different areas to diagnose neurological disorders in hands caused by various diseases. This order is regarded as a prestigious order, since researchers are particularly important in order to reach a large market. The reason is that scientists are important for verification of new examination methods which paves the way for broader sales efforts.

The order means that VibroSense Dynamics in short time succeeded to sell three systems to neurophysiological clinics which show that these clinics are a strategic target group for the company.

- We have in short time sold systems to two important institutions in Sweden and Denmark. The neurophysiological departments in Lund / Malmö and in Herlev represent important bridgeheads for broader marketing efforts, says Ulf Rogers, Marketing Director at VibroSense Dynamics AB

- During the first three months of current fiscal year, i.e. from July to September, the company's net sales has increased by over 60%, compared with the entire previous fiscal year, which is very promising, says Toni Speidel, CEO at VibroSense Dynamics

Toni Speidel, CEO, VibroSense Dynamics AB, +46 40 650 14 12, info@vibrosense.com, www.vibrosense.com


VibroSense Dynamics AB (public) develops and markets efficient systems for early detection and diagnosis of peripheral sensory neuropathy, i.e. disease of large nerve fibres and nerve trunks in the legs and arms.

The Company, founded in 2005, is listed on the Small Cap list AktieTorget since May 2015. The product portfolio includes a CE-marked medical device, the VibroSense Meter, for diagnosis of impaired sensitivity in the hands.


About Us

VibroSense Dynamics AB (public) develops and markets efficient systems for early detection and diagnosis of peripheral sensory neuropathy, i.e. disease of large nerve fibers and nerve trunks in the legs and arms. The Company, founded in 2005, is listed on the Small Cap list AktieTorget since May 2015. The product portfolio includes a CE-marked medical device, the VibroSense Meter, for diagnostics of impaired sensitivity in the hands. www.vibrosense.com

Subscribe

Documents & Links